about
Congenital Zika virus infection induces severe spinal cord injuryAltered Natural Killer Cell Function in HIV-Exposed Uninfected InfantsLower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infantsKnowledge and practice of prechewing/prewarming food by HIV-infected women.Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study.Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population.Low vitamin D status among pregnant Latin American and Caribbean women with HIV Infection.Opportunistic and other infections in HIV-infected children in Latin America compared to a similar cohort in the United StatesLimits and patterns of cytomegalovirus genomic diversity in humans.Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.Quality assurance program for peripheral blood mononuclear cell cryopreservation.Three postpartum antiretroviral regimens to prevent intrapartum HIV infectionMissed opportunities for prevention of mother-to-child transmission of HIV-1 in the NISDI Perinatal and LILAC cohorts.Association of Body Mass Index of HIV-1-Infected Pregnant Women and Infant Weight, Body Mass Index, Length, and Head Circumference: The NISDI Perinatal Study.Adherence to antiretroviral prophylaxis during early infancy in Latin America.Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean.Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries.Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population.Severe Vitamin D Deficiency in Human Immunodeficiency Virus-Infected Pregnant Women is Associated with Preterm Birth.Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes.Development and optimization of a sensitive TaqMan® real-time PCR with synthetic homologous extrinsic control for quantitation of Human cytomegalovirus viral load.Characterizing human cytomegalovirus reinfection in congenitally infected infants: an evolutionary perspective.Development of criteria for identifying neonatal near-miss cases: analysis of two WHO multicountry cross-sectional studies.Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection.Excess respiratory viral infections and low antibody responses among HIV-exposed, uninfected infants.Usefulness of blood and urine samples collected on filter paper in detecting cytomegalovirus by the polymerase chain reaction technique.Vitamin A, vitamin E, iron and zinc status in a cohort of HIV-infected mothers and their uninfected infants.Prechewing and prewarming food for HIV-exposed children: a prospective cohort experience from Latin America.Human cytomegalovirus glycoprotein B genotypes in Brazilian mothers and their congenitally infected infants.Early-onset bacterial infection in Brazilian neonates with respiratory distress: a hospital-based study.Lopinavir/ritonavir dosing during pregnancy in Brazil and maternal/infant laboratory abnormalities.Incidence, Risk Factors, and Morbidity of Acquired Postnatal Cytomegalovirus Infection Among Preterm Infants Fed Maternal Milk in a Highly Seropositive Population.Serum immunoglobulin levels and incidence of infection during the first year of life in full-term and preterm infants.Pneumococcal nasopharyngeal carriage among infants born to human immunodeficiency virus-infected mothers immunized with pneumococcal polysaccharide vaccine during gestation.Maternal antiretrovirals and hepatic enzyme, hematologic abnormalities among human immunodeficiency virus type 1-uninfected infants: the NISDI perinatal study.Missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Latin America and the Caribbean: the NISDI perinatal study.Congenital and perinatal cytomegalovirus infection in infants born to mothers infected with human immunodeficiency virus.Sepsis and neutropenia in very low birth weight infants delivered of mothers with preeclampsia.Late-onset sepsis in very low birth weight infants: a Brazilian Neonatal Research Network Study.Immunity Following Childhood Vaccinations in Perinatally HIV-Exposed Children with and without HIV Infection in Latin America.
P50
Q29571229-E1400971-C30A-4423-B8A0-004E94A7BA75Q33598613-0257C728-6DA4-467A-A219-31719E9DCDF6Q34163997-697852D6-7CB7-4904-B830-CC346EB1DCCFQ34839122-44A0E713-8427-4024-B25E-2CC9DC2A3BB9Q35156725-7ACBCDEA-672E-49E9-8204-C3014B2F16CEQ35569285-87C90DD3-D5C0-4A30-AB5D-42A1CBD7DF48Q35706037-EE61B9C6-1CC1-4C15-872D-B74329172D5CQ35799168-2616C49E-4690-4583-82C3-4E11E861AD80Q35910248-409AC3CC-71D4-4FD9-8C88-C6E4E5252534Q35924264-402768F0-9A6F-463C-A5CB-5E1553ABF9B1Q36095112-AE3C5093-393E-4D5A-BA09-9CDF973DECCEQ36662110-C093DA68-D384-4B94-8E70-306A4B2A781BQ36931935-CF6B456F-2706-4A74-B250-515E12607AC4Q37005549-A0FFED2F-018D-459E-816A-BAFF56B6F433Q37006119-514BA3DA-B98F-492F-AAE8-6823920274A3Q37029106-AC506DBE-C5A1-4273-94CF-29F120907C0FQ37399025-14E92D87-7211-48CF-BFC8-FFBD3BE13450Q37423294-159A88B4-638A-43DC-9C20-0AA3B803FD53Q37723148-88DBF2F3-2F98-49F1-B6EA-1D679A362BFFQ37836433-73DE1E2A-BA36-4F25-89F8-96917669E9D6Q38293724-9DAADEDB-8A2A-487D-839A-FB811D3921F8Q39091686-53DBDD3B-698E-44DA-A5D5-B187455E006DQ39228751-24A8EFED-485C-415F-81ED-7AAA17CC9EFAQ40261944-BD0C7C11-E0EE-45FD-8C6F-EEA116C0BB3CQ40382940-263F3E7E-359D-4EBD-9699-6B60CB468D88Q40788856-D8549C3D-4762-4D41-9480-6779D132B064Q41518965-58B0A6E0-74A4-467D-B13B-07EA641C62F1Q43186624-A00D9BE8-7755-4613-B409-DFF103896719Q43863916-DA0A2D5B-8EEE-48AB-B71F-F01F11FF3F83Q44015630-1A9B19A2-F3A4-4D46-BA65-B9AB60C376D4Q44245024-BDE6202C-9EF8-4120-BF03-C61CBA9F63AAQ44890444-340DC4B0-FC90-41D1-9B8B-8489DE8E032BQ44919497-822636DE-3127-4297-98CF-2F99D9335B12Q45370088-447D337E-A0AB-4E4D-B515-D16FE1FF9409Q45399389-580AB5EB-A71F-4E0E-BC69-48257A2343E3Q45402526-565E9379-4E8D-43C1-B958-DD2DFFA33AC7Q45757364-6AFE801B-9404-4928-A1FC-68EDDA9D098EQ47435751-F3CDCE59-678C-4379-9691-EFFB7361E59BQ47446519-EC3AEF68-D5B2-43F8-8A7B-DAB716AC7E2DQ47579533-348DA046-9094-4F28-A30C-7E7308F480A1
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Marisa M Mussi-Pinhata
@ast
Marisa M Mussi-Pinhata
@en
Marisa M Mussi-Pinhata
@es
Marisa M Mussi-Pinhata
@nl
Marisa M Mussi-Pinhata
@sl
type
label
Marisa M Mussi-Pinhata
@ast
Marisa M Mussi-Pinhata
@en
Marisa M Mussi-Pinhata
@es
Marisa M Mussi-Pinhata
@nl
Marisa M Mussi-Pinhata
@sl
altLabel
Marisa Marcia Mussi
@en
prefLabel
Marisa M Mussi-Pinhata
@ast
Marisa M Mussi-Pinhata
@en
Marisa M Mussi-Pinhata
@es
Marisa M Mussi-Pinhata
@nl
Marisa M Mussi-Pinhata
@sl
P214
P244
P1053
G-6568-2012
P106
P1153
6701324863
P21
P213
0000 0000 4561 2933
P214
P244
no2001088323
P31
P3829
P496
0000-0001-8985-1570
P735
P7859
lccn-no2001088323